Selinexor for advanced hematologic malignancies.
Saved in:
| Title: | Selinexor for advanced hematologic malignancies. |
|---|---|
| Authors: | Walker JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Garzon R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2020 Oct; Vol. 61 (10), pp. 2335-2350. Date of Electronic Publication: 2020 Jun 14. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2020.1775210 |
